(Press-News.org) While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity. But questions remain about the mechanisms underlying why some COVID patients continue to experience diminished exercise capacity while others recover without this condition.
In a study recently published in the Journal of Infectious Diseases, a team of researchers from UC San Francisco found that lower than expected exercise capacity was common among people with Long COVID and chronotropic incompetence (inadequate heart rate increase during exercise) was the most common reason. They also found reduced exercise capacity to be correlated with early post-Covid elevations of inflammatory biomarkers. In addition, they found that reactivation of Epstein-Barr virus (EBV) may be related to reduced heart rate while exercising.
First author Matthew Durstenfeld, MD, MAS, designed the cardiovascular sub-study as part of the Long-Term Impact of Infection with Novel Coronavirus (LIINC) study which was led by Michael Peluso, MD, MHS, UCSF assistant professor of Medicine. LIINC was designed to evaluate physical and mental health following COVID-19 infection by including individuals representing the full spectrum of acute illness and post-acute recovery. The study started in November 2020 using echocardiograms to evaluate cardiac conditions underlying post-COVID symptoms.
When the initial echocardiogram-based study did not reveal cardiac mechanisms of symptoms, the team amended the study protocol to conduct a second visit with the study participants one year later for advanced testing including cardiopulmonary exercise testing (CPET), cardiac magnetic resonance imaging (CMR), and ambulatory heart rhythm monitoring. Participants in the sub-study also had blood samples collected and processed for serum and plasma at their echocardiogram visit.
Sixty participants with a median age of 53 were studied at about a year and a half following COVID infection. On CPET, 49% with symptoms had reduced exercise capacity compared to 16% without symptoms. Adjusted peak VO2 (the volume of oxygen the body consumes during exercise) was 16.9% percent lower than predicted among those with symptoms. Chronotropic incompetence was a common finding, and inflammatory biomarkers and antibody levels in the first few months after COVID-19 were negatively correlated with peak VO2 more than one year later.
“The findings suggest that chronotropic incompetence – failure to achieve 80% of expected maximum heart rate while exercising - contributes to exercise limitations in long COVID,” said Durstenfeld, a cardiologist and UCSF assistant professor of Medicine. “We also found evidence of EBV reactivation in all individuals with chronotropic incompetence, however, we found no evidence of myocarditis, cardiac dysfunction, or clinically significant arrhythmias.”
The authors note the clinical diagnostic challenge that patients with symptoms present when there are no objective findings of cardiac dysfunction on multimodality cardiopulmonary testing. They suggest translational and proof-of-concept clinical research to characterize distinct phenotypes and mechanisms of post-acute COVID symptoms is urgently needed to identify potential therapies.
Until additional therapies are available, the authors believe individuals living with reduced exercise capacity may benefit from exercise training to improve their symptoms. Patient advocates have raised important concerns about the safety of exercise in those with overlapping myalgic encephalitis/chronic fatigue syndrome.
“Although exercise is unlikely to cure Long COVID, preliminary data suggest that exercise training is the only intervention demonstrated to improve exercise capacity, symptoms and quality of life,” said Durstenfeld. “Given patient concerns that exercise may worsen symptoms for some people, we need to rigorously study the role of exercise in Long COVID.”
Authors: Other UCSF authors include Michael J. Peluso, Punita Kaveti, Christopher Hill, Danny Li, Erica Sander, Shreya Swaminathan, Victor M. Arechiga, Scott Lu, Sarah A Goldberg, Rebecca Hoh, Ahmed Chenna, Brandon C. Yee, John W. Winslow, Christos J. Petropoulos, J. Daniel Kelly, David V. Glidden, Timothy J. Henrich, Jeffrey N. Martin, Yoo Jin Lee, Mandar A. Aras, Carlin S. Long, Donald J. Grandis, Steven G. Deeks, Priscilla Y. Hsue
Funding: This work was supported by US NIH/NLBI and NIH/NIAID grants and philanthropic gifts from Charles W. Swanson and the Ed and Pearl Fein Foundation. For other funding, see the study.
About UCSF Health: UCSF Health is recognized worldwide for its innovative patient care, reflecting the latest medical knowledge, advanced technologies and pioneering research. It includes the flagship UCSF Medical Center, which is a top-ranked specialty hospital, as well as UCSF Benioff Children’s Hospitals, with campuses in San Francisco and Oakland, Langley Porter Psychiatric Hospital and Clinics, UCSF Benioff Children’s Physicians and the UCSF Faculty Practice. These hospitals serve as the academic medical center of the University of California, San Francisco, which is world-renowned for its graduate-level health sciences education and biomedical research. UCSF Health has affiliations with hospitals and health organizations throughout the Bay Area. Visit https://ucsfhealth.org. Follow UCSF Health on Facebook or on Twitter.
ucsf.edu | Facebook.com/ucsf | Twitter.com/ucsf | YouTube.com/ucsf
Why do some long Covid patients continue to have difficulty exercising?
UCSF researchers use advanced cardiopulmonary and biomarker testing to assess reduced exercise tolerance and symptoms
ELSE PRESS RELEASES FROM THIS DATE:
AI used to advance drug delivery system for glaucoma and other chronic diseases
Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells. The project, a collaboration with researchers from the University of Maryland, holds promise for advancing new and more tolerable drug treatments for common chronic blinding eye diseases, including glaucoma and macular degeneration, which affect 3 million and about 20 million people in the United States, respectively. Current drug therapies ...
Epigenetic profiling identifies potential COPD treatment targets
Impaired function of lung fibroblast is considered causative for symptoms of the incurable lung disease COPD (Chronic Obstructive Pulmonary Disease). Using high-resolution epigenetic profiling, German and British scientists have now identified potential targets for COPD treatment. The team detected early epigenetic changes in the genome of COPD fibroblasts, providing new insights into the disease pathogenesis and potential therapeutic avenues. COPD, affecting approximately 600 million people globally, is characterized by chronic inflammation, progressive airway narrowing, and alveolar destruction. Despite its global prevalence, ...
CHOP researchers comprehensively assess the safety of using your head in youth soccer
Philadelphia, May 24, 2023 – Repeatedly heading a soccer ball has been previously associated with negative long-term brain health for professional players. However, in a new study from researchers at the Minds Matter Concussion Program at Children’s Hospital of Philadelphia (CHOP), a small number of repeated soccer headers equivalent to a throw-in did not cause immediate neurophysiological deficits for teens, suggesting that limited soccer heading exposure in youth sports may not result in irreversible harm if players are properly trained. The ...
Case study reveals potentially lethal side effects of lecanemab for treatment of Alzheimer's disease
Amsterdam, May 24, 2023 – In a noteworthy case study published in the Journal of Alzheimer’s Disease investigators report autopsy findings in a 65-year-old woman with Alzheimer’s disease (AD) who received three open label infusions of the experimental anti-amyloid beta (Aβ) antibody drug lecanemab. Four days after the last infusion, she experienced stroke symptoms and died several days later due to multifocal intracerebral hemorrhage despite attempts at therapeutic intervention. Neuropathologic findings reflected ...
How can universities better understand students’ experiences of violence and victimisation?
Researchers from City, University of London, in collaboration with the University of Surrey, De Montfort University, Universities UK (UUK) and the National Centre (NatCen) for Social Research have conducted the first pilot study into students’ experiences of all forms of violence and victimisation at UK universities. The Violence at University project, led by Dr Carrie-Anne Myers, Reader in the Department of Sociology and Criminology at City, aimed to investigate whether an effective tool could be developed for tracking when, where and how incidents take place. Tackling violence and harassment has been high on universities’ agenda for several years. Hate crime has ...
Use of AI: Placebo effect increases risk-taking
Human augmentation technologies refer to technological aids that enhance human abilities. They include things like exoskeletons, but also augmented reality headsets. A study at the Chair of Human-Centered Ubiquitous Media at LMU has now shown that users have high expectations of the effects of these technologies. As soon as they believe that AI is enhancing their cognitive abilities, they increase their risk-taking. And they do this independently of whether the AI is actually assisting them. “The hype around AI applications affects the expectations of users. This can lead to riskier behavior,” says Steeven Villa, doctoral researcher ...
Mixing metals for improved performance
NEWPORT NEWS, VA – A teenage fascination with metals has led to a prestigious early-career award for a superconducting radiofrequency (SRF) materials scientist at the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility. Shreyas Balachandran has been chosen to receive the ICMC Cryogenic Materials Award for Excellence, presented annually to an individual under 40 who has demonstrated innovation, impact and international recognition for their work in advancing the knowledge of cryogenic materials. “It’s ...
SwRI’s Dr. Peter Lee named STLE Fellow
SAN ANTONIO — May 24, 2023 —Dr. Peter Lee of Southwest Research Institute’s Tribology Research and Evaluations Section has been named a Fellow of the Society of Tribologists and Lubrication Engineers (STLE). An STLE fellowship recognizes society members with significant contributions over 20 years of active practice in the field of tribology and lubrication engineering. These contributions must meet a standard considered by STLE above and beyond those typically expected of a scientist or engineer. Tribology is the study of lubrication, friction ...
Phytophthora “the plant destroyer” meets its match with a new identification tool
Known as the “plant destroyer,” the genus Phytophthora is considered one of the most important groups of plant pathogens—causing significant economic and environmental losses throughout history and into today. There are over 200 identified species in the Phytophthora genus. These pathogens, and those yet to be identified, can spread quickly due to the increasing rate of global trade, e-commerce, and travel. Rapid identification is therefore critical for effective plant disease management. While several international online resources for Phytophthora identification ...
Engineers at UMass Amherst harvest abundant clean energy from thin air, 24/7
Researchers describe the “generic Air-gen effect”—nearly any material can be engineered with nanopores to harvest, cost effective, scalable, interruption-free electricity AMHERST, Mass. – A team of engineers at the University of Massachusetts Amherst has recently shown that nearly any material can be turned into a device that continuously harvests electricity from humidity in the air. The secret lies in being able to pepper the material with nanopores less than 100 nanometers in diameter. The research appeared in the journal Advanced Materials. “This is very exciting,” ...
LAST 30 PRESS RELEASES:
Making table tennis accessible for blind players #Acoustics23
Twice daily electrical stimulation may boost mental processes in Alzheimer’s disease
Young age at first menstrual cycle linked to heightened diabetes risk in mid-life
State abortion access key factor in future US doctors’ training (residency) choices
Tobacco related annual medical spend of US Minorities who smoke double that of White peers
Singing in the rain: Why the bundengan sounds better wet #Acoustics23
Limitations of asteroid crater lakes as climate archives
AAAS announces addition of Biomaterials Research to Science Partner Journal program
Picking up good vibrations: The surprising physics of the didjeridu #Acoustics23
Bacteria's mucus maneuvers: Study reveals how snot facilitates infection
Shuqing Xu receives ERC Consolidator Grant for his research on the evolution in ecological communities in response to climate change
Study of sourdough starter microbiomes to boost bread quality and safety
UT receives National Institute of Justice awards for forensics research
Newly identified biomarkers may detect early cognitive decline via blood test
Researchers predict climate change-driven reduction in beneficial plant microbes
Addicted to your phone? New tool identifies overuse of digital media
International consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Depression, constipation, and urinary tract infections may precede MS diagnosis
Chemists create organic molecules in a rainbow of colors
NCCN summit navigates solutions for financial and other cancer-related hardships
Incarcerated women punished at higher rates for minor infractions than men, UTEP study shows
Conference on microplastics in water: characterization, cure and prevention
Dorothee Dormann receives an ERC Consolidator Grant to support her research into neurodegenerative diseases
Reducing the energy consumption of software: Sebastian Erdweg receives ERC Consolidator Grant
Study finds plant nurseries are exacerbating the climate-driven spread of 80% of invasive species
Jefferson Lab site grows with addition of Applied Research Center
Texas A&M receives $1.8 million NIH grant to support bone health in people with down syndrome
Membrane raft redox signaling contributes to visfatin-induced inflammation and kidney damage
New study highlights COVID-19’s adaptive strategy for infection
Type 1 diabetes: B cell-derived natural antibodies suppress autoimmune pathogenesis[Press-News.org] Why do some long Covid patients continue to have difficulty exercising?
UCSF researchers use advanced cardiopulmonary and biomarker testing to assess reduced exercise tolerance and symptoms